Long term use of anti acid drug may increase risk of bladder cancer, finds Study
Written By : Dr. Nandita Mohan
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2021-08-28 04:15 GMT | Update On 2021-08-28 05:02 GMT
Advertisement
In a large population study conducted by a team of researchers from the Center for Public Health, Queen's University, Belfast, County Antrim, UK, it has been observed that the use of ranitidine particularly long-term use was associated with an increased risk of bladder cancer.
The study is published in the American Journal of Gatroenterology.
Ranitidine has been shown to contain the carcinogen N-nitrosodimethylamine and increase urinary N-nitrosodimethylamine in humans. Cardwell, Chris R. and colleagues investigated whether ranitidine use is associated with increased bladder cancer risk.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.